Abstract
e11549 Background: Multiple endocrine and chemotherapies are used for hormone receptor-positive (HR+), human epidermal growth factor receptor-negative (HER2-) advanced breast cancer (aBC). Clinical...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
